OBJECTIVES: To review clinical and laboratory findings in patients with SARS-Cov-2 (COVID-19) related acute pancreatitis. METHODS: This systematic review was based on a database search for articles of COVID-19 related acute pancreatitis in adult patients with confirmed COVID-19 infection that included age, gender, presenting symptoms, the onset of symptoms, laboratory values, imaging findings and exclusion of common causes of pancreatitis. RESULTS: Altogether 35 articles comprising 37 patients were included. Acute pancreatitis was the first presentation of COVID-19 in 43% of patients, concurrent with general or respiratory symptoms in 14% of patients or delayed after general or pulmonary symptoms by an average of 10 ± 5 d (range, 1 - 19 d) in 43% of patients. Serum amylase and lipase levels were elevated in 87% and 100% of patients. In 50% and 84%, amylase and lipase levels exceeded three-fold the upper normal limit. Pancreatic necrosis was reported in 6% of patients and in 12% of patients, the pancreas appeared normal. Three patients died. CONCLUSIONS: We conclude that the bi-modal pattern of the onset of symptoms supports both the cytotoxic and the immune-related pathogenesis of the pancreatic injury. Acute pancreatitis may be the first symptom of COVID-19 infection. Necrosis of the pancreas is rare.

4th Department of Internal Medicine 1st Faculty of Medicine General University Hospital Prague Charles University Prague Czech Republic

Department of Anesthesiology and Intensive Care 1st Faculty of Medicine General University Hospital Prague Charles University Prague Czech Republic

Department of Radiology 1st Faculty of Medicine General University Hospital Prague Charles University Prague Czech Republic

Zobrazit více v PubMed

Liu F, Long X, Zhang B, et al. . ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020;18:2128–2130. PubMed PMC

Inamdar S, Benias PC, Liu Y, et al. . Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis. Gastroenterology. 2020;159:2226–2228. PubMed PMC

Cheung KS, Hung IFN, Chan PPY, et al. . Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81–95. PubMed PMC

Dalan R, Bornstein SR, El-Armouche A, et al. . The ACE-2 in COVID-19: foe or Friend? Horm Metab Res. 2020;52:257–263. PubMed PMC

El-Kurdi B, Khatua B, Rood C, et al. . Mortality from coronavirus disease 2019 increases with unsaturated fat and may be reduced by early calcium and albumin supplementation. Gastroenterology. 2020;159:1015–1018. PubMed PMC

Akarsu C, Karabulut M, Aydin H, et al. . Association between acute pancreatitis and COVID-19: could pancreatitis be the missing piece of the puzzle about increased mortality rates? J Investig Surg. 2020;1–7. PubMed

Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. PubMed PMC

Banks PA, Bollen TL, Dervenis C, et al. . Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–111. PubMed

Rawla P, Bandaru SS, Vellipuram AR.. Review of infectious etiology of acute pancreatitis. Gastroenterol Res. 2017;10:153–158. PubMed PMC

Spinelli A, Pellino G.. COVID‐19 pandemic: perspectives on an unfolding crisis. Br J Surg. 2020;107:785–787. PubMed PMC

Wang F, Wang H, Fan J, et al. . Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia. Gastroenterology. 2020;159:367–370. PubMed PMC

Barlass U, Wiliams B, Dhana K, et al. . Marked elevation of lipase in COVID-19 disease: a cohort study. Clin Transl Gastroenterol. 2020;11(7):e00215. PubMed PMC

Pezzilli R, Centanni S, Mondoni M, et al. Patients with COVID-19 interstitial pneumonia exhibit pancreatic hyperenzymemia and not acute pancreatitis. Res Square. 2020. DOI:10.21203/rs.3.rs-50275/v1. PubMed DOI PMC

Rathi S, Sharma A, Patnaik I, et al. . Hyperlipasemia in COVID-19: statistical significance vs clinical relevance. Clin Transl Gastroenterol. 2020;11:e00261. PubMed PMC

Zippi M, Hong W, Traversa G, et al. . Involvement of the exocrine pancreas during COVID-19 infection and possible pathogenetic hypothesis: a concise review. Infez Med. 2020;28:507–515. PubMed

Meireles PA, Bessa F, Gaspar P, et al. . Acalculous acute pancreatitis in a COVID-19 patient. Eur J Case Rep. 2020;7:001710. PubMed PMC

Ye Q, Wang B, Zhang T, et al. . The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am J Physiol - Gastrointest Liver Physiol. 2020;319:G245–52. PubMed PMC

Wong SH, Lui RN, Sung JJ.. Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020;35:744–748. PubMed

D’Amico F, Baumgart DC, Danese S, et al. . Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 2020;18:1663–1672. PubMed PMC

Pancreatic Injury in Patients with SARS-Cov-2 (COVID-19) Infection: A Retrospective Analysis of CT Findings